http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009518404-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 |
| filingDate | 2006-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009518404-A |
| titleOfInvention | Androgen receptor modulator (N-3H-imidazo [4,5-B] pyridin-2-ylmethyl) -2-fluoro-4-methyl-3-oxo-4-aza-androst-1-en-17-beta Carboxamide polymorphs |
| abstract | The compound of structural formula I is a tissue selective modulator of the androgen receptor (AR). These compounds can be used to strengthen reduced muscle tone, as well as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, fractures, bone damage after bone reconstruction, myopathy, embrittlement, aging skin , Male hypogonadism, female postmenopausal symptoms, atherosclerosis, hypercholesterolemia, hyperlipidemia, obesity, irreproducible anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV Weakness, prostate cancer, benign prostatic hyperplasia (BPH), abdominal adiposity, metabolic syndrome, type II diabetes, cancer categorization, Alzheimer's disease, muscular dystrophy, cognitive decline, sexual dysfunction, sleep apnea, depression, premature ovary For the treatment of conditions caused by androgen deficiency, such as deficiencies and autoimmune diseases, or can be alleviated by androgen administration, alone or in combination with other active agents It is. |
| priorityDate | 2005-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1006.